Edition:
India

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

5.38USD
20 Apr 2018
Change (% chg)

$-0.24 (-4.27%)
Prev Close
$5.62
Open
$5.60
Day's High
$5.65
Day's Low
$5.35
Volume
28,957
Avg. Vol
80,602
52-wk High
$19.74
52-wk Low
$3.43

Chart for

About

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunothera... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $15.70
Shares Outstanding(Mil.): 38.41
Dividend: --
Yield (%): --

Financials

  SLS.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -0.86 -- --
ROI: -59.58 14.84 14.38
ROE: -79.40 16.34 16.07

BRIEF-Sellas Life Sciences Announces Appointment Of Gene Mack As Chief Financial Officer & Treasurer

* SELLAS LIFE SCIENCES ANNOUNCES APPOINTMENT OF GENE MACK AS CHIEF FINANCIAL OFFICER & TREASURER

20 Apr 2018

BRIEF-Sellas Life Sciences Announces Positive Interim Data From Phase 2B Neuvax Clinical Trial In Combination With Herceptin

* SELLAS LIFE SCIENCES ANNOUNCES POSITIVE INTERIM DATA FROM PHASE 2B NEUVAX™ (NELIPEPIMUT-S) CLINICAL TRIAL IN COMBINATION WITH HERCEPTIN® IN HER2 1+/2+ BREAST CANCER PATIENTS

02 Apr 2018

BRIEF-Sellas Life Sciences Announces $10.7 Mln Private Placement

* SELLAS LIFE SCIENCES ANNOUNCES $10,700,000 PRIVATE PLACEMENT

07 Mar 2018

Competitors

Earnings vs. Estimates